Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study. (Q54029744)

23 May 2018

title

Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study. (English)

1 reference

23 May 2018

main subject

pulmonary hypertension

1 reference

5

1 reference

23 May 2018

author name string

O I Miller

1

1 reference

23 May 2018

S F Tang

2

1 reference

23 May 2018

A Keech

3

1 reference

23 May 2018

N B Pigott

4

1 reference

23 May 2018

D S Celermajer

6

1 reference

23 May 2018

language of work or name

English

0 references

publication date

1 October 2000

1 reference

23 May 2018

published in

The Lancet

1 reference

23 May 2018

volume

356

1 reference

23 May 2018

page(s)

1464-1469

1 reference

23 May 2018

issue

9240

1 reference

23 May 2018

Pulmonary hypertensive crises following surgery for congenital heart defects in young children.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Diagnosis and management of postoperative pulmonary hypertensive crisis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Pulmonary hypertension in children: perioperative management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Vascular endothelial cells synthesize nitric oxide from L-arginine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

L-arginine and substance P reverse the pulmonary endothelial dysfunction caused by congenital heart surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Inhaled nitric oxide in congenital heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Inhaled nitric oxide for postoperative pulmonary hypertension in patients with congenital heart defects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Pulmonary vascular resistance in complete atrioventricular septal defect. A comparison between children with and without Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Increased perioperative risk following repair of congenital heart disease in Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Guidelines for the safe administration of inhaled nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Safety guidelines for use of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Preoperative risk-of-death prediction model in heart surgery with deep hypothermic circulatory arrest in the neonate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Clinical problems of postoperative pulmonary vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Decreased exhaled nitric oxide may be a marker of cardiopulmonary bypass-induced injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Sildenafil ameliorates effects of inhaled nitric oxide withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Inhaled nitric oxide for the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Inhaled nitric oxide in children with severe lung disease: results of acute and prolonged therapy with two concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

Effect of therapeutic concentrations of nitric oxide on bacterial growth in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902869-5

7 January 2021

10.1016/S0140-6736(00)02869-5

Identifiers

DOI

1 reference

23 May 2018

PubMed ID

11081528

1 reference

23 May 2018